{"id":"influsplit-ssw-2005-2006","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Injection site reactions (pain, redness, swelling)"},{"rate":"5-15","effect":"Myalgia"},{"rate":"5-10","effect":"Headache"},{"rate":"1-5","effect":"Fever"},{"rate":"5-10","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a split-virion influenza vaccine containing inactivated viral antigens from three influenza strains (A/H1N1, A/H3N2, and B) for the 2005/2006 season. The vaccine works by presenting these antigens to the immune system, triggering both humoral (antibody) and cellular immune responses that provide protection against infection with matching circulating influenza strains.","oneSentence":"Influsplit SSW is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:33:22.665Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention (2005/2006 season)"}]},"trialDetails":[{"nctId":"NCT00372255","phase":"PHASE4","title":"Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-11-17","conditions":"Influenza","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Influsplit SSW® 2005/2006","genericName":"Influsplit SSW® 2005/2006","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"Influsplit SSW 2005/2006 is a small molecule intervention used to study the immunogenicity and tolerability of the vaccine in children aged 6-13 years with influenza. It was investigated in a phase IV clinical trial (NCT00372255) sponsored by GlaxoSmithKline.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}